Ryan J. Watts
President and CEO at Denali Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Denali Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2024 | Denali Therapeutics Inc. | Open-market sale | โ2,260 | $23.79 | $53,765 |
| Mar 29, 2024 | Denali Therapeutics Inc. | Gift | โ40,000 | โ | โ |
| Feb 13, 2024 | Denali Therapeutics Inc. | Open-market sale | โ9,589 | $17.29 | $165,794 |
| Jan 9, 2024 | Denali Therapeutics Inc. | Open-market sale | โ7,818 | $19.78 | $154,640 |
| Jan 5, 2024 | Denali Therapeutics Inc. | Open-market sale | โ17,483 | $19.43 | $339,695 |
| Jan 3, 2024 | Denali Therapeutics Inc. | Grant or award | +89,520 | โ | โ |
| Aug 21, 2023 | Denali Therapeutics Inc. | Open-market sale | โ2,309 | $22.59 | $52,160 |
| Aug 10, 2023 | Denali Therapeutics Inc. | Option exercise | +2,526 | $0.68 | $1,718 |
| Aug 10, 2023 | Denali Therapeutics Inc. | Open-market sale | โ2,526 | $25.03 | $63,226 |
| Jun 16, 2023 | Denali Therapeutics Inc. | Option exercise | +50,000 | $0.68 | $34,000 |
| Jun 16, 2023 | Denali Therapeutics Inc. | Open-market sale | โ50,000 | $31.40 | $1,570,000 |
| Apr 21, 2023 | Denali Therapeutics Inc. | Option exercise | +24,800 | $0.68 | $16,864 |
| Apr 21, 2023 | Denali Therapeutics Inc. | Open-market sale | โ24,800 | $25.15 | $623,720 |
| Apr 20, 2023 | Denali Therapeutics Inc. | Option exercise | +200 | $0.68 | $136 |
| Apr 20, 2023 | Denali Therapeutics Inc. | Open-market sale | โ200 | $25.00 | $5,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.